Pluripotent Stem Cells: Current Understanding and Future Directions

Pluripotent stem cells have the ability to undergo self-renewal and to give rise to all cells of the tissues of the body. However, this definition has been recently complicated by the existence of distinct cellular states that display these features. Here, we provide a detailed overview of the family of pluripotent cell lines derived from early mouse and human embryos and compare them with induced pluripotent stem cells. Shared and distinct features of these cells are reported as additional hallmark of pluripotency, offering a comprehensive scenario of pluripotent stem cells.

[1]  R. Beddington,et al.  An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. , 1989, Development.

[2]  G. Pan,et al.  NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. , 2008, Cell stem cell.

[3]  Philipp Kapranov,et al.  Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.

[4]  Kevin Eggan,et al.  Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells , 2005, Science.

[5]  G. Pan,et al.  FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. , 2011, Cell stem cell.

[6]  David R. Liu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[7]  ping wang,et al.  Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells , 2011, Cell Research.

[8]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[9]  M. Torres-Padilla,et al.  Control of ground-state pluripotency by allelic regulation of Nanog , 2012, Nature.

[10]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[11]  G. Pan,et al.  The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. , 2011, Cell stem cell.

[12]  K. Plath,et al.  Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. , 2012, Human molecular genetics.

[13]  K. Miyazono,et al.  Roles of TGF-β family signals in the fate determination of pluripotent stem cells. , 2014, Seminars in cell & developmental biology.

[14]  J. Thomson,et al.  BMP4 initiates human embryonic stem cell differentiation to trophoblast , 2002, Nature Biotechnology.

[15]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[16]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[17]  Jennifer A. Erwin,et al.  Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations , 2010, Cell.

[18]  H. Schöler,et al.  Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. , 1989, The EMBO journal.

[19]  Yi Zhang,et al.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application. , 2013, Cell stem cell.

[20]  H. Ng,et al.  The transcriptional regulation of pluripotency , 2012, Cell Research.

[21]  Jieying Zhu,et al.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs , 2012, Nature Genetics.

[22]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[23]  H. Ng,et al.  Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. , 2013, Cell stem cell.

[24]  K. Zaret,et al.  Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome , 2013, Cell cycle.

[25]  G. Stein,et al.  Pluripotency: Toward a gold standard for human ES and iPS cells , 2009, Journal of cellular physiology.

[26]  K. Hochedlinger,et al.  Chromatin dynamics during cellular reprogramming , 2013, Nature.

[27]  T. Cantz,et al.  Induced pluripotent stem cells generated without viral integration , 2009, Hepatology.

[28]  J. Utikal,et al.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. , 2007, Cell stem cell.

[29]  R. Jaenisch,et al.  Blimp1 Expression Predicts Embryonic Stem Cell Development In Vitro , 2011, Current Biology.

[30]  J. Lawrence,et al.  X‐inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected , 2008, Journal of cellular physiology.

[31]  L. Hyslop,et al.  Downregulation of NANOG Induces Differentiation of Human Embryonic Stem Cells to Extraembryonic Lineages , 2005, Stem cells.

[32]  H. Onoe,et al.  Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease , 2012, Stem cells.

[33]  D. Henrique,et al.  Generation and Characterization of a Novel Mouse Embryonic Stem Cell Line with a Dynamic Reporter of Nanog Expression , 2013, PloS one.

[34]  I. Amit,et al.  Derivation of novel human ground state naive pluripotent stem cells , 2013, Nature.

[35]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[36]  Jun S. Song,et al.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.

[37]  Ana D. Lopez,et al.  Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent , 2004, Stem cells.

[38]  J. Thomson,et al.  Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. , 2004, Endocrinology.

[39]  Kristi A. Hohenstein,et al.  Regulation of Self‐Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells , 2008, Stem cells.

[40]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[41]  Á. Rada-Iglesias,et al.  Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease , 2011, Genome Medicine.

[42]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[43]  Greg Donahue,et al.  Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome , 2012, Cell.

[44]  T. Seki,et al.  Methods of induced pluripotent stem cells for clinical application. , 2015, World journal of stem cells.

[45]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[46]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[47]  Austin G Smith,et al.  FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment , 2007, Development.

[48]  Shaorong Gao,et al.  Cell Stem Cell Brief Report Ips Cells Can Support Full-term Development of Tetraploid Blastocyst-complemented Embryos Cell Stem Cell Brief Report , 2022 .

[49]  C. Lengner,et al.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs , 2010, Proceedings of the National Academy of Sciences.

[50]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[51]  R. Benezra,et al.  Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. , 2012, Stem cells and development.

[52]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[53]  R. Wesselschmidt.  The teratoma assay: an in vivo assessment of pluripotency. , 2011, Methods in molecular biology.

[54]  Natalia B. Ivanova,et al.  Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. , 2012, Cell stem cell.

[55]  F. Claessens,et al.  Dynamic Switching of Active Promoter and Enhancer Domains Regulates Tet1 and Tet2 Expression during Cell State Transitions between Pluripotency and Differentiation , 2015, Molecular and Cellular Biology.

[56]  K. Hochedlinger,et al.  Tgfβ Signal Inhibition Cooperates in the Induction of iPSCs and Replaces Sox2 and cMyc , 2009, Current Biology.

[57]  R. Jaenisch,et al.  Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells. , 2011, Angewandte Chemie.

[58]  C. Pereira,et al.  Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.

[59]  H. Schöler,et al.  OCT4: dynamic DNA binding pioneers stem cell pluripotency. , 2014, Biochimica et biophysica acta.

[60]  David A. Orlando,et al.  Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-β Signaling , 2011, Cell.

[61]  Marielle Afanassieff,et al.  A short G1 phase is an intrinsic determinant of naïve embryonic stem cell pluripotency. , 2013, Stem cell research.

[62]  T. Mikkelsen,et al.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.

[63]  Wenjun Guo,et al.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.

[64]  J. Lawrence,et al.  X‐Inactivation Status Varies in Human Embryonic Stem Cell Lines , 2005, Stem cells.

[65]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[66]  Deepak M. Gupta,et al.  A nonviral minicircle vector for deriving human iPS cells , 2010, Nature Methods.

[67]  Peter G Schultz,et al.  Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4 , 2009, Proceedings of the National Academy of Sciences.

[68]  S. Schwartz,et al.  Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.

[69]  B. Garcia,et al.  Proteomic and genomic approaches reveal critical functions of H3K9 methylation and Heterochromatin Protein-1γ in reprogramming to pluripotency , 2013, Nature Cell Biology.

[70]  M. Surani,et al.  DNA methylation dynamics during the mammalian life cycle , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[71]  Norio Nakatsuji,et al.  Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells , 2001, Current Biology.

[72]  L. D. Del Priore,et al.  Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients , 2015, Stem cell reports.

[73]  D. Melton,et al.  Generation of Functional Human Pancreatic β Cells In Vitro , 2014, Cell.

[74]  J. Nichols,et al.  BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3 , 2003, Cell.

[75]  A. Brivanlou,et al.  Contribution of human embryonic stem cells to mouse blastocysts. , 2006, Developmental biology.

[76]  Shinya Yamanaka,et al.  Generation of mouse-induced pluripotent stem cells with plasmid vectors , 2010, Nature Protocols.

[77]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[78]  Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development , 2011, Nature.

[79]  B. Lim,et al.  Activin/Nodal Signaling Controls Divergent Transcriptional Networks in Human Embryonic Stem Cells and in Endoderm Progenitors , 2011, Stem cells.

[80]  R. Weksberg,et al.  Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation , 2011, Human molecular genetics.

[81]  O. Dreesen,et al.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. , 2011, Cell stem cell.

[82]  Hongwei Yu,et al.  Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome , 2004, BMC Developmental Biology.

[83]  H. Schöler,et al.  Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. , 1996, Development.

[84]  J. Nichols,et al.  Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human , 2014, Cell.

[85]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[86]  I. Khrebtukova,et al.  MPSS profiling of human embryonic stem cells , 2004, BMC Developmental Biology.

[87]  Marcos J. Araúzo-Bravo,et al.  Direct reprogramming of human neural stem cells by OCT4 , 2009, Nature.

[88]  M. Trotter,et al.  Activin/Nodal signalling maintains pluripotency by controlling Nanog expression , 2009, Development.

[89]  Tamar Dvash,et al.  Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells , 2010, PloS one.

[90]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[91]  A. Terzic,et al.  Metabolic plasticity in stem cell homeostasis and differentiation. , 2012, Cell stem cell.

[92]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[93]  A. Cimmino,et al.  L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation , 2013, Stem cell reports.

[94]  M. Richards,et al.  Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells , 2002, Nature Biotechnology.

[95]  S. Baylin,et al.  Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency‐Associated Genes , 2010, Stem cells.

[96]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[97]  G. Daley,et al.  Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation , 2013, Science.

[98]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[99]  J. Nichols,et al.  Validated germline-competent embryonic stem cell lines from nonobese diabetic mice , 2009, Nature Medicine.

[100]  M. Pellegrini,et al.  X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations , 2008, Proceedings of the National Academy of Sciences.

[101]  A. Smith,et al.  Embryo-derived stem cells: of mice and men. , 2001, Annual review of cell and developmental biology.

[102]  R. Rowntree,et al.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[103]  J. Nichols,et al.  Naive and primed pluripotent states. , 2009, Cell stem cell.

[104]  Takashi Hiiragi,et al.  Stochastic patterning in the mouse pre-implantation embryo , 2007, Development.

[105]  Jennifer Nichols,et al.  The Transcriptional and Epigenomic Foundations of Ground State Pluripotency , 2012, Cell.

[106]  Peter Reinhardt,et al.  Investigating human disease using stem cell models , 2014, Nature Reviews Genetics.

[107]  O. Mirochnitchenko,et al.  Preclinical Studies for Induced Pluripotent Stem Cell-based Therapeutics* , 2013, The Journal of Biological Chemistry.

[108]  Alan Trounson,et al.  Stem Cell Therapies in Clinical Trials: Progress and Challenges. , 2015, Cell stem cell.

[109]  G. Blin,et al.  The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression , 2012, Development.

[110]  Sean C. Bendall,et al.  IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro , 2007, Nature.

[111]  C. Lengner,et al.  Metastable pluripotent states in NOD-mouse-derived ESCs. , 2009, Cell stem cell.

[112]  Ping Li,et al.  Embryonic stem cell self‐renewal pathways converge on the transcription factor Tfcp2l1 , 2013, The EMBO journal.

[113]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[114]  Sheng Ding,et al.  Reprogramming of human primary somatic cells by OCT4 and chemical compounds. , 2010, Cell stem cell.

[115]  J. A. Bloomfield,et al.  Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming , 2015, Cell proliferation.

[116]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[117]  R. Pedersen,et al.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells , 2005, Journal of Cell Science.

[118]  T. Mikkelsen,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[119]  R. Lund,et al.  Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. , 2006, Cloning and stem cells.

[120]  P. Park,et al.  Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells , 2012, Nature Genetics.

[121]  Sanjiv J. Shah,et al.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions. , 2014, JACC. Heart failure.

[122]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[123]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[124]  R. McKay,et al.  New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.

[125]  H. Onoe,et al.  Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. , 2011, Journal of Parkinson's disease.

[126]  Holm Zaehres,et al.  LIF/STAT3 Signaling Fails to Maintain Self‐Renewal of Human Embryonic Stem Cells , 2004, Stem cells.

[127]  K. Plath,et al.  Female human iPSCs retain an inactive X chromosome. , 2010, Cell stem cell.

[128]  M. Peschanski,et al.  Human pluripotent stem cells for disease modelling and drug screening. , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[129]  M. Blasco,et al.  The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.

[130]  H. Deng,et al.  Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.

[131]  H. Redl,et al.  Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.

[132]  Alessandra Giorgetti,et al.  Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[133]  M. Trotter,et al.  Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.

[134]  H. Schöler,et al.  A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. , 1989, The EMBO journal.

[135]  O. Lindvall,et al.  Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. , 2012, Cell reports.

[136]  Suk-Ho Lee,et al.  Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. , 2011, The Journal of clinical investigation.

[137]  J. Nolta,et al.  Concise Review: Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products , 2012, Stem cells.

[138]  Huidong Shi,et al.  Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. , 2009, Blood.

[139]  M. Gut,et al.  Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. , 2013, Cell stem cell.

[140]  A. Heck,et al.  Investigating the role of FGF‐2 in stem cell maintenance by global phosphoproteomics profiling , 2011, Proteomics.

[141]  J. Gurdon,et al.  The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. , 1962, Journal of embryology and experimental morphology.

[142]  Stephen Dalton,et al.  Activin A Efficiently Specifies Definitive Endoderm from Human Embryonic Stem Cells Only When Phosphatidylinositol 3‐Kinase Signaling Is Suppressed , 2007, Stem cells.

[143]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[144]  Ariel J. Levine,et al.  TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells , 2005 .

[145]  T. Burdon,et al.  Oct‐4 Knockdown Induces Similar Patterns of Endoderm and Trophoblast Differentiation Markers in Human and Mouse Embryonic Stem Cells , 2004, Stem cells.

[146]  D. Melton,et al.  Turning straw into gold: directing cell fate for regenerative medicine , 2011, Nature Reviews Genetics.

[147]  J. Thomson,et al.  Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells , 2005, Nature Methods.

[148]  Petr Svoboda,et al.  Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency , 2014, Development.

[149]  S. Rastan,et al.  X-chromosome deletions in embryo-derived (EK) cell lines associated with lack of X-chromosome inactivation. , 1985, Journal of embryology and experimental morphology.

[150]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[151]  V. Tabar,et al.  Pluripotent stem cells in regenerative medicine: challenges and recent progress , 2014, Nature Reviews Genetics.

[152]  Jennifer Nichols,et al.  Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.

[153]  K. Boheler,et al.  Embryonic stem cells: prospects for developmental biology and cell therapy. , 2005, Physiological reviews.

[154]  A. van Oudenaarden,et al.  Allele-specific detection of single mRNA molecules in situ , 2013, Nature Methods.

[155]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[156]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[157]  B Fischer,et al.  Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. , 1993, Journal of reproduction and fertility.

[158]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[159]  P. Rosenfeld,et al.  Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies , 2015, The Lancet.

[160]  K. Plath,et al.  Generation of human induced pluripotent stem cells from dermal fibroblasts , 2008, Proceedings of the National Academy of Sciences.

[161]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[162]  A. Schnerch,et al.  Distinguishing Between Mouse and Human Pluripotent Stem Cell Regulation: The Best Laid Plans of Mice and Men , 2010, Stem cells.

[163]  J. Nichols,et al.  Klf4 reverts developmentally programmed restriction of ground state pluripotency , 2009, Development.

[164]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[165]  H. Schöler,et al.  Generation of Human‐Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 , 2009, Stem cells.

[166]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[167]  A. Higuchi,et al.  Generation of pluripotent stem cells without the use of genetic material , 2015, Laboratory Investigation.

[168]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[169]  Qi Zhou,et al.  iPS cells produce viable mice through tetraploid complementation , 2009, Nature.

[170]  Rudolf Jaenisch,et al.  Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. , 2011, Cell stem cell.

[171]  H. Hirai,et al.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. , 2011, The Biochemical journal.

[172]  Angelique M. Nelson,et al.  Derivation of naïve human embryonic stem cells , 2014, Proceedings of the National Academy of Sciences.

[173]  J. Takahashi,et al.  Therapeutic application of stem cell technology toward the treatment of Parkinson's disease. , 2013, Biological & pharmaceutical bulletin.

[174]  Donald W. Fink.  FDA Regulation of Stem Cell–Based Products , 2009, Science.

[175]  R. Young,et al.  Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency , 2014, Cell stem cell.

[176]  Sara Reardon,et al.  Japan stem-cell trial stirs envy , 2014, Nature.

[177]  F. Tang,et al.  Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylation , 2013, EMBO reports.

[178]  Paul Pavlidis,et al.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. , 2009, Cell stem cell.

[179]  Robert Lanza,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .

[180]  B. Snel,et al.  Tyrosine Phosphorylation Profiling in FGF-2 Stimulated Human Embryonic Stem Cells , 2011, PloS one.

[181]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[182]  Austin G Smith,et al.  Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation , 2012, Nature Cell Biology.

[183]  Mohammad M. Karimi,et al.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells , 2013, Nature.

[184]  Qi Zhou,et al.  Brief Report: Combined Chemical Treatment Enables Oct4‐Induced Reprogramming from Mouse Embryonic Fibroblasts , 2011, Stem cells.

[185]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[186]  Chad A. Cowan,et al.  Derivation of embryonic stem-cell lines from human blastocysts. , 2004, The New England journal of medicine.

[187]  Weiqi Zhang,et al.  Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules , 2011, Cell Research.

[188]  Xiu-Jie Wang,et al.  Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesis , 2011, Cell Research.

[189]  A. Reinisch,et al.  Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression , 2012, Circulation.

[190]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[191]  Jianming Jiang,et al.  Klf2 is an essential factor that sustains ground state pluripotency. , 2014, Cell stem cell.

[192]  Marcos J. Araúzo-Bravo,et al.  A unique Oct4 interface is crucial for reprogramming to pluripotency , 2013, Nature Cell Biology.

[193]  Hidenori Akutsu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[194]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[195]  Hsu-hsin Chen,et al.  The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells , 2008, Cell.

[196]  K. Eggan,et al.  Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.

[197]  Mikael Huss,et al.  Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. , 2010, Developmental cell.

[198]  Heiko Lickert,et al.  Biallelic expression of nanog protein in mouse embryonic stem cells. , 2013, Cell stem cell.